Aymeric Sève
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 detection and testing 6
- HIV/AIDS drug development and treatment 4
-
- COVID-19 epidemiological studies 2
- Co-authors
- Laurent Hocqueloux (9 shared papers)Thiérry Prazuck (9 shared papers)Jérôme Guinard (5 shared papers)Camelia Gubavu (5 shared papers)Laura Courtellemont (2 shared papers)Gilles Pialoux (3 shared papers)Anna Lucie Fournier (1 shared paper)Renaud Verdon (1 shared paper)
In The Last Decade
Aymeric Sève
23 papers receiving 3.7k citations
Aymeric Sève's Hit Papers
Peers
Comparison fields: 5 of 113
- Infectious Diseases 3.3k
- Modeling and Simulation 214
- Animal Science and Zoology 409
- Health 179
- Immunology 334
Countries citing papers authored by Aymeric Sève
This map shows the geographic impact of Aymeric Sève's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aymeric Sève with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aymeric Sève more than expected).
Fields of papers citing papers by Aymeric Sève
This network shows the impact of papers produced by Aymeric Sève. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aymeric Sève. The network helps show where Aymeric Sève may publish in the future.
Co-authors
The 25 scholars most cited alongside Aymeric Sève, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization Hit paper breakdown → | 2021 | 1550 |
| 2 | Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Hit paper breakdown → | 2021 | 1172 |
| 3 | Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies Hit paper breakdown → | 2021 | 500 |
| 4 | Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies Hit paper breakdown → | 2022 | 219 |
| 5 | 2021 | 99 | |
| 6 | 2021 | 46 | |
| 7 | 2022 | 41 | |
| 8 | 2020 | 37 | |
| 9 | 2022 | 28 | |
| 10 | 2021 | 27 | |
| 11 | 2021 | 13 | |
| 12 | 2023 | 13 | |
| 13 | 2022 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2025 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2023 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 1992 | 2 | |
| 20 | 2019 | 2 |
About Aymeric Sève
Aymeric Sève is a scholar working on Infectious Diseases, Modeling and Simulation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Virology, having authored 25 papers that have together received 3.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 detection and testing (6 papers), HIV/AIDS drug development and treatment (4 papers), Respiratory Support and Mechanisms (3 papers), COVID-19 epidemiological studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Diphtheria, Corynebacterium, and Tetanus (1 paper). The work is most often cited by research in Infectious Diseases (3.3k citations), Modeling and Simulation (214 citations), Animal Science and Zoology (409 citations), Health (179 citations) and Immunology (334 citations). Aymeric Sève has collaborated with scholars based in France, Belgium and Monaco. Frequent co-authors include Laurent Hocqueloux, Thiérry Prazuck, Jérôme Guinard, Camelia Gubavu, Laura Courtellemont, Gilles Pialoux, Anna Lucie Fournier, Renaud Verdon, Astrid Vabret and Jean‐Jacques Parienti. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Nature, Nature Medicine, Clinical Infectious Diseases and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.